Evidence map›Paper›PMID 18550542›Full record

ArticleThe Journal of biological chemistry2008

A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation.

Kyoungja Hong, Liguang Lou, Sandhya Gupta, Fernando Ribeiro-Neto, Daniel L Altschuler

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Resveratrol Induces the Fasting State and Alters Circadian Metabolism in Hepatocytes.Plant foods for human nutrition (Dordrecht, Netherlands) · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Lipid biology of breast cancer.Biochimica et biophysica acta · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kyoungja HongDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Liguang Lou
Sandhya Gupta
Fernando Ribeiro-Neto
Daniel L Altschuler
University of Pittsburgh · US

Funding

Transduction of the cAMP signal by Rap1R01CA071649 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALTSCHULER, DANIEL L · 2004 to 2008
$1.3M
RAPLB AS AN EFFECTOR OF CAMP MEDIATED MITOGENIC ACTIONR29CA071649 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALTSCHULER, DANIEL L · 1997 to 2001
$256k
NCI NIH HHS CA071649
6 · The paper itself

Abstract

Rap1b has been implicated in the transduction of the cAMP mitogenic signal. It is phosphorylated and activated by cAMP, and its expression in models where cAMP is mitogenic leads to proliferation and tumorigenesis. Akt is a likely downstream effector of cAMP-Rap1 action. cAMP elevation induced a rapid and transient Akt inhibition that required activated and phosphorylated Rap1b. However, the mechanism(s) by which cAMP-Rap regulates Akt remains unclear. Here we show that (i) upstream regulators, PIK and PDK1, are not the target(s) of the cAMP inhibitory action; (ii) constitutively active Akt and calyculin A-stimulated Akt are resistant to cAMP inhibition, suggesting the action of a phosphatase; (iii) cAMP increases the rate of Akt dephosphorylation, directly implicating an Akt-phosphatase; (iv) Epac- and protein kinase A (PKA)-specific analogs synergistically inhibit Akt, indicating the involvement of both cAMP-dependent effector pathways; (v) H89 and dominant negative Epac 279E block cAMP-inhibitory action; (vi) Epac associates in a complex with Akt and PP2A, and the associated-phosphatase activity is positively modulated by cAMP in a PKA- and Rap1-dependent manner; (vii) like its action on Akt inhibition, PKA- and Epac-specific analogs synergistically activate Epac-associated PP2A; and (viii) dominant negative PP2A blocks cAMP-inhibitory action. Thus, we uncovered a novel cAMP-Epac/PKA-Rap1b-PP2A signaling module involved in Akt regulation that may represent a physiological event in the process of cAMP stimulation of thyroid mitogenesis.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsCell LineCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsGuanine Nucleotide Exchange FactorsInhibitory Concentration 50IsoquinolinesProtein Phosphatase 2Proto-Oncogene Proteins c-aktrap1 GTP-Binding ProteinsRatsSignal TransductionSulfonamidesThyroid GlandCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme InhibitorsGuanine Nucleotide Exchange FactorsIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidePpp2ca protein, ratProtein Phosphatase 2Proto-Oncogene Proteins c-aktrap1 GTP-Binding ProteinsRapgef3 protein, ratSulfonamides

Identifiers

PMID18550542
PMCPMC2517008
OpenAlexW2066542032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.